Here are five things to know:
1. Researchers conducted a retrospective review to assess the contribution of surgeon-specific cost variability and patient-reported outcomes to overall ACDF variability.
2. The study included 431 patients from a prospective registry database undergoing elective primary ACDF by five different surgeons.
3. Direct and indirect 90-day costs were compared across each surgeon as well as PROs. Predicted costs were calculated based on patient comorbidities.
4. Despite surgeon-specific cost variations, there were no differences in PROs across the surgeons.
5. The study authors found no apparent correlation between increased surgeon-specific costs and 90-day PROs. The researchers conclude intersurgeon cost variation can be improved without compromising PROs.
More articles on spine:
Top 10 Spine Review articles: Aug. 13-17
Drs. Yair Gozal, Kelly-Ann Patrice & more: 7 spine, neurosurgeons making headlines
Allied Pain & Spine Institute director to be featured on radio show: 4 details
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.